Dana-Farber Cancer Inst — Boston, Massachusetts

Dana-Farber Cancer Inst is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Inst has participated in 5 clinical trials.

Therapeutic areas: Melanoma, Breast Cancer, Metastasis.

Sponsors: Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Inst?

Dana-Farber Cancer Inst has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Inst conducted?

Dana-Farber Cancer Inst has 5 clinical trials on record. Their work covers Melanoma, Breast Cancer, Metastasis.

Is Dana-Farber Cancer Inst accredited by Crixeo Health?

Dana-Farber Cancer Inst has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Inst?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.